Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Clay

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Expert Opinion on Biological Therapy|October 20, 2006
Recent clinical progress in virus-based therapies for cancerChristopher Y Woo, Takuya Osada, Timothy M Clay, et al.
Expert Opinion on Biological Therapy|March 22, 2007
Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapyBenjamin F Johnson, Timothy M Clay, Amy C Hobeika, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Dendritic cell vaccinesPaul J Mosca, H Kim Lyerly, Timothy M Clay, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2011
Depletion of human regulatory T cellsAmy C Hobeika, Michael A Morse, Takuya Osada, et al.
Current Opinion in Molecular Therapeutics|March 3, 2007
Immunotherapeutic targeting of Wilms' tumor proteinYalonda Hutchings, Takuya Osada, Christopher Y Woo, et al.
Cancer Treatment and Research|October 11, 2005
Antigen recognition and T-cell biologyMichael I Nishimura, Jeffrey J Roszkowski, Tamson V Moore, et al.
Journal of Virology|November 24, 2006
Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivoZachary C Hartman, Anne Kiang, Ruth S Everett, et al.
Blood|June 4, 2008
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccinesMichael A Morse, Amy C Hobeika, Takuya Osada, et al.
Virology|February 19, 2008
Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement systemZachary C Hartman, Daniel M Appledorn, Delila Serra, et al.
Current Opinion in Molecular Therapeutics|April 3, 2003
Proteomics for monitoring immune responses to cancer vaccinesPaul J Mosca, H Kim Lyerly, C Denise Ching, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Expert Opinion on Biological Therapy|October 20, 2006
Recent clinical progress in virus-based therapies for cancerChristopher Y Woo, Takuya Osada, Timothy M Clay, et al.
Expert Opinion on Biological Therapy|March 22, 2007
Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapyBenjamin F Johnson, Timothy M Clay, Amy C Hobeika, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Dendritic cell vaccinesPaul J Mosca, H Kim Lyerly, Timothy M Clay, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2011
Depletion of human regulatory T cellsAmy C Hobeika, Michael A Morse, Takuya Osada, et al.
Current Opinion in Molecular Therapeutics|March 3, 2007
Immunotherapeutic targeting of Wilms' tumor proteinYalonda Hutchings, Takuya Osada, Christopher Y Woo, et al.
Cancer Treatment and Research|October 11, 2005
Antigen recognition and T-cell biologyMichael I Nishimura, Jeffrey J Roszkowski, Tamson V Moore, et al.
Journal of Virology|November 24, 2006
Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivoZachary C Hartman, Anne Kiang, Ruth S Everett, et al.
Blood|June 4, 2008
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccinesMichael A Morse, Amy C Hobeika, Takuya Osada, et al.
Virology|February 19, 2008
Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement systemZachary C Hartman, Daniel M Appledorn, Delila Serra, et al.
Current Opinion in Molecular Therapeutics|April 3, 2003
Proteomics for monitoring immune responses to cancer vaccinesPaul J Mosca, H Kim Lyerly, C Denise Ching, et al.
Pageof 8